Conference abstractPublished 11 Sep 2017
Conformational plasticity of the GPCR activating parathyroid hormone
Martin-Luther-University, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The parathyroid hormone (PTH) from glands controls the blood calcium and phosphate level via its G-protein coupled receptors (GPCR). PTH, an 84-residue peptide, is intrinsically disordered and adopts an -helical conformation for N-terminal residues 15-34 upon binding to the extra cellular domain of the receptor. These residues form the core cross- structure in fast forming amyloid fibrils, which is possibly a storage form of the PTH hormone and thus a functional amyloid conformation. NMR-detected phosphorylation at the N-terminus of PTH by cell-lysate of parathyroid glands still allows hormone binding to the ectodomain but abolishes GPCR activation in vivo. The same inhibition can be achieved by a Zn2+ anthracenyl-terpyridine complex binding to the N-terminus of PTH. PTH (1-34) is already an approved drug against osteoporosis, where this Zn2+ coordination complex now allows to control receptor activation not by targeting the receptor itself but at the level of its agonist. The N-terminal residues of PTH thus can adopt various functional conformations depending on the local environment including binding partners, posttranslational modifications, or amyloid fibrils, and we found a conformation selective metal coordination complex to inhibit receptor activation.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Jochen Balbach”